← All trials
NCT06447597
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2024
- Primary completion
- Jun 30, 2026
- Completion date
- Jun 30, 2026
- First posted
- Jun 7, 2024
- Last posted
- Oct 31, 2024
- Enrollment
- 104
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai Pharmaceuticals Holding Co., LtdLead sponsor
- Shanghai Pharmaceuticals Holding Co., LtdCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.